|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 103, 1218-1223, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
JJ Pelton, MJ Kowalyshyn and SM Keller
Photodynamic therapy has been proposed as a new modality for the local
treatment of neoplasms limited to the pleural surface. Clinical use of
photodynamic therapy will involve exposure of large surface areas of normal
intrathoracic organs to tumoricidal doses of photodynamic therapy. This
study details the pathologic changes that occur within the lung, heart,
trachea, and diaphragm of Sprague-Dawley rats after administration of
tumoricidal photodynamic therapy. Animals were injected with the
photosensitizer Photofrin-II (Quadralogic Technologies, Vancouver, B.C.,
Canada), 10 mg/kg intraperitoneally, 24 hours before surface illumination
of a portion of the target organ with gold vapor laser light (628 nm) (124
joules/cm2). Control animals were treated with light alone. After
endotracheal intubation and mechanical ventilation, the lung and heart were
exposed via left thoracotomy. The trachea was dissected in the neck, and
the diaphragm was visualized via celiotomy. One site was treated per
animal. Animals were killed at 24 hours, 48 hours, 72 hours, 1 week, 1
months, and 6 months after therapy. Histologic injury was numerically
assessed by a single observer blinded to treatment and time of organ
harvest. The Wilcoxon matched-pair signed-rank test was used to determine
the statistical significance of differences between treated and control
groups. Twenty- four hours after treatment the lung, heart, and trachea of
rats subjected to photodynamic therapy demonstrated parenchymal injury (p
less than 0.05). The diaphragm showed delayed injury 72 hours after therapy
(p less than 0.05). Microscopic pulmonary changes included alveolar and
endothelial disruption, intraalveolar hemorrhage, and fibrin deposition.
Coagulation necrosis of myocardial fibers extending through the epicardium
to involve up to 50% of myocardial thickness was observed. The diaphragm
showed mesothelial hyperplasia with necrosis of superficial skeletal
muscle. No similar gross or microscopic changes were present in the organs
of control animals, or more than 48 hours after treatment in the trachea of
animals that received photodynamic therapy. Photodynamic therapy induces a
spectrum of tissue-specific injury, which may affect its usefulness in
subsequent clinical trials.
ARTICLES
Intrathoracic organ injury associated with photodynamic therapy
Department of Surgical Oncology, Fox Chase Cancer Center, Temple University School of Medicine, Philadelphia, PA 19111.
This article has been cited by other articles:
![]() |
D. I. Fielding, G. A. Buonaccorsi, A. J. MacRobert, A. M. Hanby, M. R. Hetzel, and S. G. Bown Fine-Needle Interstitial Photodynamic Therapy of the Lung Parenchyma: Photosensitizer Distribution and Morphologic Effects of Treatment Chest, February 1, 1999; 115(2): 502 - 510. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |